XML 41 R21.htm IDEA: XBRL DOCUMENT
v3.21.1

Revenues (Tables) | 3 Months Ended
--- | ---
Apr. 02, 2021
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregation of Revenue | Revenues consisted of the following (in thousands):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2021 |  | 2020 |  |
Product revenues: |  |  |  |  |  |  |  |  |
Gross product revenues |  |  |  |  | $ | 314,205 |  |  | $ | 252,566 |  |  |
Discounts and allowances |  |  |  |  | (86,993) |  |  | (58,686) |  |  |
Net product revenues |  |  |  |  | 227,212 |  |  | 193,880 |  |  |
Collaboration revenues: |  |  |  |  |  |  |  |  |
License revenues |  |  |  |  | 27,528 |  |  | 20,879 |  |  |
Collaboration services revenues |  |  |  |  | 15,490 |  |  | 12,156 |  |  |
Total collaboration revenues |  |  |  |  | 43,018 |  |  | 33,035 |  |  |
Total revenues |  |  |  |  | $ | 270,230 |  |  | $ | 226,915 |  |  |
Net product revenues by product were as follows (in thousands):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2021 |  | 2020 |  |
CABOMETYX |  |  |  |  | $ | 223,595 |  |  | $ | 189,216 |  |  |
COMETRIQ |  |  |  |  | 3,617 |  |  | 4,664 |  |  |
Net product revenues |  |  |  |  | $ | 227,212 |  |  | $ | 193,880 |  |  |
Schedule of Concentration Risks | The percentage of total revenues by customer who individually accounted for 10% or more of our total revenues were as follows:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2021 |  | 2020 |  |
Affiliates of CVS Health Corporation |  |  |  |  | 15 | % |  | 18 | % |  |
Affiliates of AmerisourceBergen Corporation |  |  |  |  | 14 | % |  | 11 | % |  |
Affiliates of McKesson Corporation |  |  |  |  | 13 | % |  | 15 | % |  |
Ipsen Pharma SAS |  |  |  |  | 13 | % |  | 13 | % |  |
Affiliates of Optum Specialty Pharmacy |  |  |  |  | 9 | % |  | 12 | % |  |
The percentage of trade receivables by customer who individually accounted for 10% or more of our trade receivables were as follows:
| March 31, 2021 |  | December 31, 2020 |  |  |  |
Ipsen Pharma SAS | 22 | % |  | 23 | % |  |  |  |
Affiliates of McKesson Corporation | 18 | % |  | 12 | % |  |  |  |
Affiliates of AmerisourceBergen Corporation | 16 | % |  | 11 | % |  |  |  |
Affiliates of CVS Health Corporation | 12 | % |  | 11 | % |  |  |  |
Takeda Pharmaceutical Company Limited | 5 | % |  | 10 | % |  |  |  |
Revenues Disaggregated by Geographic Region | Revenues by geographic region were as follows (in thousands):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2021 |  | 2020 |  |
U.S. |  |  |  |  | $ | 229,957 |  |  | $ | 196,596 |  |  |
Europe |  |  |  |  | 33,806 |  |  | 29,036 |  |  |
Japan |  |  |  |  | 6,467 |  |  | 1,283 |  |  |
Total revenues |  |  |  |  | $ | 270,230 |  |  | $ | 226,915 |  |  |
Schedule of Activities and Ending Reserve Balances for Significant Categories of Discounts and Allowances | The activities and ending reserve balances for each significant category of discounts and allowances, which constitute variable consideration, were as follows (in thousands):
| Chargebacks, Discounts for Prompt Payment and Other |  | Other Customer Credits/Fees and Co-pay Assistance |  | Rebates |  |  |  | Total
Balance at December 31, 2020 | $ | 9,853 |  |  | $ | 3,279 |  |  | $ | 17,404 |  |  |  |  | $ | 30,536 |
Provision related to sales made in: |  |  |  |  |  |  |  |  |
Current period | 52,470 |  |  | 8,054 |  |  | 25,232 |  |  |  |  | 85,756 |
Prior periods | (27) |  |  | (2) |  |  | 1,266 |  |  |  |  | 1,237 |
Payments and customer credits issued | (49,636) |  |  | (5,622) |  |  | (15,935) |  |  |  |  | (71,193) |
Balance at March 31, 2021 | $ | 12,660 |  |  | $ | 5,709 |  |  | $ | 27,967 |  |  |  |  | $ | 46,336 |
Schedule of Other Assets and Other Liabilities | Contract assets and liabilities were as follows (in thousands):
| March 31, 2021 |  | December 31, 2020
Contract assets | $ | — |  |  | $ | — |
Contract liabilities: |  |  |
Current portion(1) | $ | 9,207 |  |  | $ | 1,790 |
Long-term portion(2) | 9,760 |  |  | 3,755 |
Total contract liabilities | $ | 18,967 |  |  | $ | 5,545 |
____________________ (1) Presented in other current liabilities in the accompanying Condensed Consolidated Balance Sheets. (2) Presented in the long-term portion of deferred revenues in the accompanying Condensed Consolidated Balance Sheets.

X
- Definition Reconciliation Of Sales Discount And Allowances Reserve Balances [Table Text Block] + References No definition available. + Details
Name: | exel_ReconciliationOfSalesDiscountAndAllowancesReserveBalancesTableTextBlock
Namespace Prefix: | exel_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration